SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-24-026414
Filing Date
2024-08-13
Accepted
2024-08-13 16:30:03
Documents
4
Effectiveness Date
2024-08-13
Reference 429
333-275547

Document Format Files

Seq Description Document Type Size
1 FORM S-8 urgn20240719_s8.htm S-8 44254
2 EXHIBIT 5.1 ex_711699.htm EX-5.1 14122
3 EXHIBIT 23.1 ex_712570.htm EX-23.1 2178
4 EXHIBIT FILING FEES ex_711700.htm EX-FILING FEES 18505
  Complete submission text file 0001437749-24-026414.txt   80329
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281520 | Film No.: 241202108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)